Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

[Transglutaminase and neurodegenerative diseases].

Liu Z, Zeng J, Zeng S, Tang B, Wang J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015 Aug;32(4):562-6. doi: 10.3760/cma.j.issn.1003-9406.2015.04.025. Review. Chinese.

PMID:
26252108
2.

Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.

Iannaccone M, Titta F, Serretiello E, Monfregola M, Gentile V.

Recent Pat CNS Drug Discov. 2014;9(2):76-84. Review.

PMID:
25386917
3.

Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases.

Titta F, Iannaccone M, Martin A, Gentile V.

Recent Pat CNS Drug Discov. 2014;9(2):101-9. Review.

PMID:
24924102
4.

Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.

Iannaccone M, Titta F, Serretiello E, De Vivo G, Martin A, Gentile V.

Recent Pat CNS Drug Discov. 2013 Dec;8(3):235-42. Review.

PMID:
24286449
5.

Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.

Iannaccone M, Serretiello E, De Vivo G, Martin A, Stefanile A, Titta F, Gentile V.

Recent Pat CNS Drug Discov. 2013 Aug;8(2):161-8. Review.

PMID:
23688272
6.

Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

Grosso H, Mouradian MM.

Pharmacol Ther. 2012 Mar;133(3):392-410. doi: 10.1016/j.pharmthera.2011.12.003. Epub 2011 Dec 22. Review.

PMID:
22212614
7.

Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases.

Martin A, Giuliano A, Collaro D, De Vivo G, Sedia C, Serretiello E, Gentile V.

Amino Acids. 2013 Jan;44(1):111-8. doi: 10.1007/s00726-011-1081-1. Epub 2011 Sep 22. Review.

PMID:
21938398
8.

Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease.

Munsie L, Caron N, Atwal RS, Marsden I, Wild EJ, Bamburg JR, Tabrizi SJ, Truant R.

Hum Mol Genet. 2011 May 15;20(10):1937-51. doi: 10.1093/hmg/ddr075. Epub 2011 Feb 25.

9.

Transglutaminase activation in neurodegenerative diseases.

Jeitner TM, Muma NA, Battaile KP, Cooper AJ.

Future Neurol. 2009 Jul 1;4(4):449-467.

10.

Critical role of transglutaminase and other stress proteins during neurodegenerative processes.

Caccamo D, CurrĂ² M, Condello S, Ferlazzo N, Ientile R.

Amino Acids. 2010 Feb;38(2):653-8. doi: 10.1007/s00726-009-0428-3. Epub 2009 Dec 5. Review.

PMID:
19960212
11.

Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.

De Vivo G, Di Lorenzo R, Ricotta M, Gentile V.

Curr Med Chem. 2009;16(36):4767-73. Review.

PMID:
19929789
12.
13.

Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.

Wilhelmus MM, van Dam AM, Drukarch B.

Eur J Pharmacol. 2008 May 13;585(2-3):464-72. doi: 10.1016/j.ejphar.2008.01.059. Epub 2008 Mar 18. Review.

PMID:
18417122
14.

Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection.

Malorni W, Farrace MG, Rodolfo C, Piacentini M.

Curr Pharm Des. 2008;14(3):278-88. Review.

PMID:
18220838
15.

Transglutaminase is linked to neurodegenerative diseases.

Muma NA.

J Neuropathol Exp Neurol. 2007 Apr;66(4):258-63. Review.

PMID:
17413316
16.

Transglutaminase 2 in neurodegenerative disorders.

Ruan Q, Johnson GV.

Front Biosci. 2007 Jan 1;12:891-904. Review.

PMID:
17127346
17.

Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.

Martin A, Romito G, Pepe I, De Vivo G, Merola MR, Limatola A, Gentile V.

Curr Med Chem. 2006;13(16):1895-902. Review.

PMID:
16842200
18.

Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases.

Bailey CD, Graham RM, Nanda N, Davies PJ, Johnson GV.

Mol Cell Neurosci. 2004 Mar;25(3):493-503.

PMID:
15033177
19.

Tissue transglutaminase: a possible role in neurodegenerative diseases.

Lesort M, Tucholski J, Miller ML, Johnson GV.

Prog Neurobiol. 2000 Aug;61(5):439-63. Review.

PMID:
10748319
20.

Transglutaminase as the agent of neurodegenerative diseases due to polyglutamine expansion.

Kahlem P, Green H, Djian P.

Pathol Biol (Paris). 1998 Nov;46(9):681-2. English, French. No abstract available.

PMID:
9885815

Supplemental Content

Loading ...
Support Center